Zapiecki et al. reported a similar trend, where Cyclin D1 expression, quantified as the mean percent positive nuclear area (PPNA), was significantly higher in advanced stages (Stage I: 4.3, Stage IV: 17.5; p = 0.013), indicating its potential role in tumor progression [23]. The gene discussed is CCND1; the disease is neoplasm.